you are here: home > inthenews > meningitis vaccine supply in good shape
In January 2005, the US Food and Drug Administration approved Menactra, a vaccine to fight bacterial meningitis (meningococcal disease). However, in May 2006, the Centers for Disease Control and Prevention (CDC) recommended that children 11-12 years old should delay getting the vaccine because supplies of the vaccine were short.
Good news! The shortage is over. Sanofi Pasteur, the company that makes the vaccine, has announced that supplies of Menactra are adequate. The CDC now recommends that kids 11-12 years old, if not previously vaccinated, should be vaccinated.
The CDC and the American Academy of Pediatrics also recommends that the following people should be vaccinated:
References and Links:
Copyright © 1996-2006, Eric H. Chudler, University of Washington